Citation 1:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 378–535

Citation 2:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=outstanding%20as%20of%20April%C2%A030%2C%202025%2C,was%20146%2C527%2C832%20shares
    Location: chars 561–735

Citation 3:
    Title: Biogen PE Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/pe-ratio#:~:text=2025,29.20
    Location: chars 775–881

Citation 4:
    Title: Biogen PE Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/pe-ratio#:~:text=2025,29.20
    Location: chars 899–1005

Citation 5:
    Title: Biogen Price to Sales Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/BIIB/price-sales#:~:text=2025,4.15
    Location: chars 1025–1131

Citation 6:
    Title: Biogen Price to Book Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/price-book#:~:text=2025,2.13
    Location: chars 1150–1257

Citation 7:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=match%20at%20L493%20Contract%20manufacturing%2C,2%2C290.5
    Location: chars 1501–1651

Citation 8:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=match%20at%20L664%20GAAP%20Diluted,6
    Location: chars 1799–1989

Citation 9:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=Revenue%20from%20multiple%20sclerosis%20treatments%2C,to%20%24563%20million
    Location: chars 2099–2312

Citation 10:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=Alongside%20Skyclarys%2C%20Biogen%E2%80%99s%20rare%20disease,selling%20drug%20in%20Q1%202025
    Location: chars 2373–2631

Citation 11:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=One%20of%20those%20assets%20is,due%20to%20Medicare%20discount%20dynamics
    Location: chars 2674–2912

Citation 12:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=match%20at%20L1319%20QALSODY,423.9
    Location: chars 2964–3091

Citation 13:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=Revenue%20from%20multiple%20sclerosis%20treatments%2C,to%20%24563%20million
    Location: chars 3224–3437

Citation 14:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=treatments%2C%20such%20as%20Vumerity%20,the%20same%20period%20last%20year
    Location: chars 3500–3739

Citation 15:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=Sales%20of%20Leqembi%20in%20the,54%20million%2C%20according%20to%20Jefferies
    Location: chars 3886–4100

Citation 16:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=already%20secured%20key%20milestones%20for,EU
    Location: chars 4201–4412

Citation 17:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=For%20full,20%20benefit%20from%20foreign%20exchange
    Location: chars 4678–4867

Citation 18:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=Cash%20and%20cash%20equivalents
    Location: chars 4965–5150

Citation 19:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 5214–5371

Citation 20:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=%E2%80%9CBut%20there%E2%80%99s%20a%20new%20Biogen,continue%20to%20grow%2C%E2%80%9D%20Vibacher%20added
    Location: chars 5562–5829

Citation 21:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=setbacks%2C%20Biogen%20reported%20better,5%20billion
    Location: chars 5920–6131

Citation 22:
    Title: Biogen and Stoke Therapeutics Enter into Collaboration to
    URL: https://www.globenewswire.com/news-release/2025/02/18/3027765/0/en/Biogen-and-Stoke-Therapeutics-Enter-into-Collaboration-to-Develop-and-Commercialize-Zorevunersen-for-the-Treatment-of-Dravet-Syndrome-a-Rare-Genetic-Epilepsy-Associated-with-Refrac.html#:~:text=Stoke%20to%20receive%20%24165M%20upfront%2C,milestones%20as%20well%20as%20royalties
    Location: chars 7144–7515

Citation 23:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=setbacks%2C%20Biogen%20reported%20better,5%20billion
    Location: chars 7574–7785

Citation 24:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 7902–8059

Citation 25:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=match%20at%20L493%20Contract%20manufacturing%2C,2%2C290.5
    Location: chars 8783–8933

Citation 26:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=The%20drugmaker%20posted%20Q1%20adjusted,23%20billion%20average%20analyst%20estimate
    Location: chars 8953–9175

Citation 27:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=For%20full,20%20benefit%20from%20foreign%20exchange
    Location: chars 9277–9466

Citation 28:
    Title: Biogen and Stoke Therapeutics Enter into Collaboration to
    URL: https://www.globenewswire.com/news-release/2025/02/18/3027765/0/en/Biogen-and-Stoke-Therapeutics-Enter-into-Collaboration-to-Develop-and-Commercialize-Zorevunersen-for-the-Treatment-of-Dravet-Syndrome-a-Rare-Genetic-Epilepsy-Associated-with-Refrac.html#:~:text=Stoke%20to%20receive%20%24165M%20upfront%2C,milestones%20as%20well%20as%20royalties
    Location: chars 9651–10022

Citation 29:
    Title: Sage rebuffs Biogen bid to take it over | BioPharma Dive
    URL: https://www.biopharmadive.com/news/sage-reject-biogen-buyout-offer-strategic-review/738413/#:~:text=Biogen%20on%20Jan,Jacob%20Bell%2FBioPharma%20Dive
    Location: chars 10253–10429

Citation 30:
    Title: Sage rejects Biogen’s $469m takeover bid - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/sage-rejects-biogens-469m-takeover-bid/#:~:text=Sage%20Therapeutics%20has%20rejected%20Biogen%E2%80%99s,bid%20%E2%80%9Csignificantly%20undervalues%E2%80%9D%20the%20company
    Location: chars 10430–10687

Citation 31:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=already%20secured%20key%20milestones%20for,EU
    Location: chars 10946–11157

Citation 32:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 11339–11496

Citation 33:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=Revenue%20from%20multiple%20sclerosis%20treatments%2C,to%20%24563%20million
    Location: chars 12198–12411

Citation 34:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=treatments%2C%20such%20as%20Vumerity%20,the%20same%20period%20last%20year
    Location: chars 12412–12651

Citation 35:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=setbacks%2C%20Biogen%20reported%20better,5%20billion
    Location: chars 13232–13443

Citation 36:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=For%20full,20%20benefit%20from%20foreign%20exchange
    Location: chars 13549–13738

Citation 37:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=Cash%20flow%20from%20operations
    Location: chars 13842–14027

Citation 38:
    Title: Biogen Revenue 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/revenue#:~:text=2022%20%20,%2413%2C445
    Location: chars 14219–14336

Citation 39:
    Title: Biogen Revenue 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/revenue#:~:text=2022%20%20,%2413%2C445
    Location: chars 14344–14461

Citation 40:
    Title: Biogen Revenue 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/revenue#:~:text=2022%20%20,%2413%2C445
    Location: chars 14468–14585

Citation 41:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=match%20at%20L493%20Contract%20manufacturing%2C,2%2C290.5
    Location: chars 14592–14742

Citation 42:
    Title: Biogen EPS - Earnings per Share 2010-2025 | BIIB | MacroTrends
    URL: https://macrotrends.net/stocks/charts/BIIB/biogen/eps-earnings-per-share-diluted#:~:text=,increase%20from%202021
    Location: chars 14775–14908

Citation 43:
    Title: Biogen EPS - Earnings per Share 2010-2025 | BIIB | MacroTrends
    URL: https://macrotrends.net/stocks/charts/BIIB/biogen/eps-earnings-per-share-diluted#:~:text=,increase%20from%202021
    Location: chars 14916–15049

Citation 44:
    Title: Biogen EPS - Earnings per Share 2010-2025 | BIIB | MacroTrends
    URL: https://macrotrends.net/stocks/charts/BIIB/biogen/eps-earnings-per-share-diluted#:~:text=,increase%20from%202021
    Location: chars 15056–15189

Citation 45:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=match%20at%20L664%20GAAP%20Diluted,6
    Location: chars 15197–15387

Citation 46:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=Cash%20and%20cash%20equivalents
    Location: chars 16605–16790

Citation 47:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 17031–17188

Citation 48:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=setbacks%2C%20Biogen%20reported%20better,5%20billion
    Location: chars 17967–18178

Citation 49:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=treatments%2C%20such%20as%20Vumerity%20,the%20same%20period%20last%20year
    Location: chars 18907–19146

Citation 50:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=and%20made%20strategic%20acquisitions%20including,34%20forecast
    Location: chars 19548–19770

Citation 51:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236
    Location: chars 20305–20389

Citation 52:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=TYSABRI%20%20,
    Location: chars 20561–20668

Citation 53:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=SPINRAZA%20%20,0.2
    Location: chars 20669–20780

Citation 54:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=Biogen%20splits%20revenue%20from%20Leqembi,EU
    Location: chars 20864–21075

Citation 55:
    Title: Biogen PE Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/pe-ratio#:~:text=2025,29.20
    Location: chars 21400–21506

Citation 56:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=match%20at%20L493%20Contract%20manufacturing%2C,2%2C290.5
    Location: chars 23958–24108

Citation 57:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=match%20at%20L664%20GAAP%20Diluted,6
    Location: chars 24109–24299

Citation 58:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=,GAAP%20diluted%20EPS%20%243.02
    Location: chars 24352–24537

Citation 59:
    Title: Biogen : Q1 2025 Biogen Earnings Presentation | MarketScreener
    URL: https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/Biogen-Q1-2025-Biogen-Earnings-Presentation-49788558/#:~:text=Cash%20and%20cash%20equivalents
    Location: chars 24538–24723

Citation 60:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=The%20drugmaker%20posted%20Q1%20adjusted,23%20billion%20average%20analyst%20estimate
    Location: chars 24826–25048

Citation 61:
    Title: Biogen lowers annual earnings outlook, surpasses Q1 estimates By Investing.com
    URL: https://ng.investing.com/news/earnings/biogen-lowers-annual-earnings-outlook-surpasses-q1-estimates-1893684#:~:text=For%20full,20%20benefit%20from%20foreign%20exchange
    Location: chars 25049–25238

Citation 62:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=treatments%2C%20such%20as%20Vumerity%20,the%20same%20period%20last%20year
    Location: chars 25325–25564

Citation 63:
    Title: Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/biogens-q1-revenue-soars-past-estimates-as-rare-disease-pivot-pays-off/#:~:text=Alongside%20Skyclarys%2C%20Biogen%E2%80%99s%20rare%20disease,selling%20drug%20in%20Q1%202025
    Location: chars 25565–25823

Citation 64:
    Title: Biogen Revenue 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/revenue#:~:text=2022%20%20,%2413%2C445
    Location: chars 25879–25996

Citation 65:
    Title: Biogen EPS - Earnings per Share 2010-2025 | BIIB | MacroTrends
    URL: https://macrotrends.net/stocks/charts/BIIB/biogen/eps-earnings-per-share-diluted#:~:text=,increase%20from%202021
    Location: chars 26048–26181

Citation 66:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=Revenue%20by%20product%20is%20summarized,as%20follows
    Location: chars 26285–26431

Citation 67:
    Title: Biogen Inc. - 10Q - Quarterly Report - May 01, 2025
    URL: https://fintel.io/doc/sec-biogen-inc-875045-10q-2025-may-01-20210-236#:~:text=Rare%20Disease%3A%20%20,0.2
    Location: chars 26432–26552

Citation 68:
    Title: Biogen Price to Sales Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/BIIB/price-sales#:~:text=2025,4.15
    Location: chars 26612–26718

Citation 69:
    Title: Biogen Price to Book Ratio 2010-2025 | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/price-book#:~:text=2025,2.13
    Location: chars 26719–26826

Citation 70:
    Title: Sage rebuffs Biogen bid to take it over | BioPharma Dive
    URL: https://www.biopharmadive.com/news/sage-reject-biogen-buyout-offer-strategic-review/738413/#:~:text=Biogen%20on%20Jan,Jacob%20Bell%2FBioPharma%20Dive
    Location: chars 26906–27082

Citation 71:
    Title: Sage rejects Biogen’s $469m takeover bid - Pharmaceutical Technology
    URL: https://www.pharmaceutical-technology.com/news/sage-rejects-biogens-469m-takeover-bid/#:~:text=Sage%20Therapeutics%20has%20rejected%20Biogen%E2%80%99s,bid%20%E2%80%9Csignificantly%20undervalues%E2%80%9D%20the%20company
    Location: chars 27184–27441

Citation 72:
    Title: Biogen and Stoke Therapeutics Enter into Collaboration to
    URL: https://www.globenewswire.com/news-release/2025/02/18/3027765/0/en/Biogen-and-Stoke-Therapeutics-Enter-into-Collaboration-to-Develop-and-Commercialize-Zorevunersen-for-the-Treatment-of-Dravet-Syndrome-a-Rare-Genetic-Epilepsy-Associated-with-Refrac.html#:~:text=Stoke%20to%20receive%20%24165M%20upfront%2C,milestones%20as%20well%20as%20royalties
    Location: chars 27521–27892

Citation 73:
    Title: Biogen will stop selling its controversial Alzheimer's drug Aduhelm
    URL: https://apnews.com/article/dfb364a61e4e77da27fc055e826b9a49#:~:text=Biogen%20announced%20it%20will%20cease,decline%2C%20aimed%20at%20early%20Alzheimer%27s
    Location: chars 27988–28158

Citation 74:
    Title: Biogen - 53 Year Dividend History | BIIB | MacroTrends
    URL: https://www.macrotrends.net/stocks/charts/BIIB/biogen/dividend-yield-history#:~:text=Historical%20dividend%20payout%20and%20yield,00
    Location: chars 28212–28369

Citation 75:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=setbacks%2C%20Biogen%20reported%20better,5%20billion
    Location: chars 28482–28693

Citation 76:
    Title: Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-biogen-forecasts-2025-profit-below-expectations-2025-02-12/#:~:text=and%20made%20strategic%20acquisitions%20including,34%20forecast
    Location: chars 28694–28916

Citation 77:
    Title: Biogen reports fourth quarter and full year 2024 results and provides full year 2025 financial guidance – 1stOncology™: Cancer Intelligence Service
    URL: https://www.1stoncology.com/blog/biogen-reports-fourth-quarterfull-year-2024-resultsprovides-full-year-2025-financial-guidance1234650209/#:~:text=Total%20Revenue%20,N%2FA
    Location: chars 28991–29186

